Stay updated with breaking news from Steve Ommen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
An international clinical trial found that new drug aficamten boosts exercise capacity and quality of life for obstructive hypertrophic cardiomyopathy patients.
Telemedicine delivers the same level of care as in-person, satisfies patients and physicians and drives down healthcare costs, cardiologist Steve Ommen says.
New Mayo Clinic study finds that certain defibrillators are not used as often for patients of color.
ROCHESTER, Minn. — In recent decades, implantable cardioverter-defibrillator (ICD) use in the management of patients with hypertrophic cardiomyopathy
In recent decades, implantable cardioverter-defibrillator (ICD) use in the management of patients with hypertrophic cardiomyopathy (HCM) has